Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Pia Deichgræber"'
Autor:
Peter Durda, Laura M. Raffield, Ethan M. Lange, Nels C. Olson, Nancy Swords Jenny, Mary Cushman, Pia Deichgraeber, Niels Grarup, Anna Jonsson, Torben Hansen, Josyf C. Mychaleckyj, Bruce M. Psaty, Alex P. Reiner, Russell P. Tracy, Leslie A. Lange
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 21 (2022)
Background Monocytes/macrophages participate in cardiovascular disease. CD163 (cluster of differentiation 163) is a monocyte/macrophage receptor, and the shed sCD163 (soluble CD163) reflects monocyte/macrophage activation. We examined the association
Externí odkaz:
https://doaj.org/article/1bbd1bce4b274aeb95f236398449d416
Autor:
Torsten Lauritzen, Else-Marie Dalsgaard, Martin Bernstorff, Niels Henrik Bruun, Pia Deichgræber, Morten Fenger-Grøn
Publikováno v:
BMJ Open
Bernstorff, M, Deichgræber, P, Bruun, N H, Dalsgaard, E-M, Fenger-Grøn, M & Lauritzen, T 2019, ' A Randomised Trial Examining Cardiovascular Morbidity and All-Cause Mortality 24 years Following General Health Checks : the Ebeltoft Health Promotion Project (EHPP) ', BMJ Open, vol. 9, no. 10, e030400 . https://doi.org/10.1136/bmjopen-2019-030400
Bernstorff, M, Deichgræber, P, Bruun, N H, Dalsgaard, E-M, Fenger-Grøn, M & Lauritzen, T 2019, ' A Randomised Trial Examining Cardiovascular Morbidity and All-Cause Mortality 24 years Following General Health Checks : the Ebeltoft Health Promotion Project (EHPP) ', BMJ Open, vol. 9, no. 10, e030400 . https://doi.org/10.1136/bmjopen-2019-030400
IntroductionGlobal prevalence of risk factors for cardiovascular disease (CVD) and all-cause mortality is increasing. Treatments are available but can only be implemented if individuals at risk are identified. General health checks have been suggeste
Autor:
Nanna B. Johansen, Pia Deichgræber, Annelli Sandbæk, Mette Vinther Skriver, Holger Jon Møller, Daniel R. Witte, Bjørn Richelsen, Marit E. Jørgensen
Publikováno v:
Deichgræber, P, Witte, D R, Møller, H J, Skriver, M V, Richelsen, B, Jørgensen, M E, Johansen, N B & Sandbæk, A 2018, ' Correction to : Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort ', Diabetologia, vol. 61, no. 2, pp. 498-503 . https://doi.org/10.1007/s00125-017-4498-6
The authors have discovered a coding error in the statistical analysis syntax file used for the mixed-effect model analyses in this paper. The error has led to differences (first decimal) in the estimates for the main results.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ffdc4e6e3815d931ee6d8bd90da29c
https://pure.au.dk/portal/da/publications/correction-to(e5dcb182-bd48-4740-bad9-873b9ffc23de).html
https://pure.au.dk/portal/da/publications/correction-to(e5dcb182-bd48-4740-bad9-873b9ffc23de).html
Autor:
Signe Toft Andersen, Pia Deichgræber, Daniel Witte, Torsten Lauritzen, Henning Andersen, Annelli Sandbæk, Holger Jon Møller, Morten Charles
Publikováno v:
Andersen, S T, Deichgræber, P, Witte, D, Lauritzen, T, Andersen, H, Sandbæk, A, Møller, H J & Charles, M 2016, ' The macrophage activation marker soluble CD163 is associated with diabetic neuropathy ' .
Aarhus University
Aarhus University
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c0512ebd216c0ab4f185192a8afc0c64
https://pure.au.dk/ws/files/96574092/posterphd2016.pdf
https://pure.au.dk/ws/files/96574092/posterphd2016.pdf
Autor:
Daniel R. Witte, Pia Deichgræber, Bjørn Richelsen, Marit E. Jørgensen, Holger Jon Møller, Mette Vinther Skriver, Annelli Sandbæk, Nanna B. Johansen
Publikováno v:
Deichgræber, P, Witte, D R, Møller, H J, Skriver, M V, Richelsen, B, Jørgensen, M E, Johansen, N B & Sandbæk, A 2016, ' Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus : the ADDITION-PRO cohort ', Diabetologia, vol. 59, no. 11, pp. 2467-2476 . https://doi.org/10.1007/s00125-016-4075-4
Deichgræber, P, Witte, D R, Møller, H J, Skriver, M V, Richelsen, B, Jørgensen, M E, Johansen, N B & Sandbæk, A 2016, ' Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus : the ADDITION-PRO cohort ', Diabetologia, vol. 59/11 . https://doi.org/10.1007/s00125-016-4075-4
Deichgræber, P, Witte, D R, Møller, H J, Skriver, M V, Richelsen, B, Jørgensen, M E, Johansen, N B & Sandbæk, A 2016, ' Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus : the ADDITION-PRO cohort ', Diabetologia, vol. 59/11 . https://doi.org/10.1007/s00125-016-4075-4
Aim/hypothesis: Our aim was to investigate the association between the macrophage-activation marker soluble CD163 (sCD163), adiponectin, C-reactive protein (CRP) and changes in glycaemia, insulin resistance and insulin secretion in individuals at hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efdf5a656e4fef784e8c77721a9821e9
https://portal.findresearcher.sdu.dk/da/publications/c30eee5f-fb5b-4790-b5d9-a25f4ecea57e
https://portal.findresearcher.sdu.dk/da/publications/c30eee5f-fb5b-4790-b5d9-a25f4ecea57e
Autor:
Ljubica Vukelic Andersen, Jes S. Lindholt, Pia Deichgraeber, Peter Vestergaard, Lars Frost, Leif Spange Mortensen
Publikováno v:
Andersen, L V, Vestergaard, P, Deichgraeber, P, Lindholt, J S, Mortensen, L S & Frost, L 2008, ' Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis ', Heart, vol. 94, no. 12, pp. 1607-13 . https://doi.org/10.1136/hrt.2007.135657
Udgivelsesdato: 2008-Dec BACKGROUND: Warfarin for stroke prevention in patients with atrial fibrillation (AF) is well documented. However, it has not been examined in the prevention of systemic embolism. OBJECTIVES: To evaluate the efficacy of warfar